Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maria Grazia
Maria Grazia Busana, Fabbrico IT
| Patent application number | Description | Published |
|---|---|---|
| 20100126564 | CERAMIC TILE WITH SURFACE FUNCTIONALIZED WITH PHOTOVOLTAIC CELLS - Described herein is a tile made up of: a ceramic base body having an absorption of water equal to or less than 0.5 wt %; a photovoltaic cell applied directly to a first surface of the ceramic base body; a device containing the electrical and/or electronic part, applied to a second surface of the ceramic base body; and an electrical connector, designed to connect the photovoltaic cell electrically to the device containing the electrical and/or electronic part through the ceramic base body. | 05-27-2010 |
Maria Grazia Canaline, Piane Di Mocogno (mo) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110165275 | PREPARATION FOR THE TREATMENT OF THE ERECTILE DISORDER - The preparation for the treatment of the erectile disorder comprises tarragon, lemon balm and fennel mixed with at least one solvent means. | 07-07-2011 |
Maria Grazia Cascone, Massarosa IT
| Patent application number | Description | Published |
|---|---|---|
| 20090136576 | Biocompatible composition for replacing/regenerating tissues - A biocompatible composition for replacing/regenerating articular tissues, in particular tissues of the nucleus pulposus but also not articular tissues such as bony tissues, providing a hydrogel matrix comprising a first and a second natural polymer, cells adapted to regenerate the tissue of the disc core, a cross linking agent suitable to cross-link at least one of said natural polymers in situ, thus giving to the biocompatible composition an appropriate resistance, and molecules adapted to stimulate the growth and/or the differentiation of cells, wherein one of the two natural polymers is sodium alginate. In a particular exemple, the above described composition before the cross-linking step has a starting density such that it is injectable. In particular, the cross linking action on sodium alginate is caused by a cross linking agent contained in biodegradable polymeric particles, released in a controlled way from natural polymers, for example gelatin, or starting from synthetic polymers, for example polylactic acid or copolymers of acid lactic-glycolic acid. | 05-28-2009 |
Maria Grazia Cusi, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20080305091 | Poly-Epitope Peptide Derived from Thymidylate Synthase Having Immunological and Anti-Tumour Activity - The present invention concerns a peptide having anti-tumour activity and its related pharmaceutical compositions. In particular, the invention concerns a peptide with anti-tumour preventive and therapeutic activity, also in combination with other known anti-tumour compounds such as, for example, 5-fluorouracil. | 12-11-2008 |
Maria Grazia De Simoni, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20080226655 | Kallikrein-Inhibitor Therapies - Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient. | 09-18-2008 |
| 20090062195 | Kallikrein-Inhibitor Therapies - Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient. | 03-05-2009 |
| 20090117130 | KALLIKREIN-INHIBITOR THERAPIES - Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient. | 05-07-2009 |
Maria Grazia De Simoni, Milaan IT
| Patent application number | Description | Published |
|---|---|---|
| 20080305993 | Use of C1 Inhibitor for the Prevention of Ischemia-Reperfusion Injury - The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke. | 12-11-2008 |
Maria Grazia Di Certo, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20100216712 | NUCLEIC ACID CODIFYING FOR A UTROPHIN TRANSCRIPTION SPECIFIC REGULATING PROTEIN, PROTEIN CODIFIED THEREBY AND USES THEREOF - The present invention relates to a nucleic acid molecule comprising a nucleotide sequence codifying for a protein characterized in having at least four zinc finger domains and in modulating the transcription of the utrophin gene by binding to a nucleotidic sequence comprised in a utrophin gene untranscribed regulatory sequence. Protein codified thereby and uses thereof. | 08-26-2010 |
Maria Grazia Frontoso, Pollena Trocchia IT
| Patent application number | Description | Published |
|---|---|---|
| 20100026981 | ELASTIC BACKSCATTERING AND BACKREFLECTION LIDAR DEVICE FOR THE CHARACTERIZATION OF ATMOSPHERIC PARTICLES - A method is described for the characterization of atmospheric particles by means of a lidar device. The method provides to send a laser pulse in the atmosphere, a part of which is directly backscattered by the particles in the atmosphere. A reflecting optical device is provided, that is positioned at a predetermined distance d from the lidar device, whereby a part of the laser pulse that directly reaches the reflecting device is backreflected and is later backscattered by the particles in the atmosphere thus generating a counterpropagating backscattering signal directed towards the reflecting device, which signal reaches the reflecting device and is backreflected towards the lidar device. The lidar device detects the direct backscattering and counterpropagating signals. The optical characteristics of the particles are determined on the basis of the direct backscattering signal and the counterpropagating backscattering signal. | 02-04-2010 |
Maria-Grazia Martinoli, Trois-Rivieres CA
| Patent application number | Description | Published |
|---|---|---|
| 20100298434 | NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION - There is provided methods for the prevention of dopaminergic cell death for neuroprotection and the prevention or slow down of progression of Parkinson's disease. Particularly, the invention relates to methods for protecting and/or preventing dopaminergic cell death by the administration of a compound or agent inhibiting the translocation of Nur77 to the cytosol of dopaminergic cells. The invention also relates to methods for identifying such compounds or agents. | 11-25-2010 |
Maria-Grazia Pizza, Emeryville, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090324633 | Immunogens from Uropathogenic Escherichia Coli - Disclosed herein are various genes that can be included in immunogenic compositions specific for pathogenic | 12-31-2009 |
Maria-Grazia Spiga, Cary, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20110301228 | GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA - The presently disclosed subject matter provides an inducible vector comprising a therapeutic gene. In some embodiments a method is provided for treating steroid glaucoma. In some embodiments a method is provided for preventing elevated intraocular pressure in a subject receiving steroid treatment. In some embodiments a method is provided for reversing elevated intraocular pressure in a subject receiving steroid treatment. In some embodiments a steroid treatment method is provided. Also provided are pharmaceutical compositions comprising an inducible vector. | 12-08-2011 |